Big Pharma Watch

BIG PHARMA WATCH: DRUG MAKER PRICES CHEMO TREATMENT TEN TIMES ABOVE THE MARKET AS PATIENTS FACE SHORTAGES

Oct 28, 2022

Areva Pharmaceuticals Price-Gouges Cancer Patients Who Rely on Older Oncology Read More

BIG PHARMA WATCH: BIG PHARMA HIKED PRICES FASTER THAN INFLATION ON MORE THAN 1,200 DRUGS FROM 2021-2022

Oct 4, 2022

HHS Reports Demonstrate Cost of Big Pharma Egregious Pricing Practices and Read More

BIG PHARMA WATCH: BIOGEN TO PAY U.S. GOVERNMENT $900M FOR ANTI-COMPETITIVE KICKBACK SCHEME

Sep 27, 2022

Biogen Agrees to Settle Case Over Illegally Paying Doctors to Push Brand Name Read More

BIG PHARMA WATCH: CEO UNDERCUTS OWN INDUSTRY’S DOOM AND GLOOM RHETORIC ON RECENT DRUG PRICING SOLUTIONS

Sep 22, 2022

Novartis Exec Calls Policy to Keep Price Hikes Below Inflation Read More

BIG PHARMA WATCH: REPORT FINDS BIG PHARMA’S “PERVASIVE” PATENT ABUSE “THE ROOT OF THE DRUG PRICING CRISIS”

Sep 15, 2022

I-MAK Analysis Finds Anti-Competitive Practices That Extend Exclusivity Will Read More

BIG PHARMA WATCH: STUDY FINDS BIG PHARMA PROFITS THROUGH ANTI-COMPETITIVE KICKBACK SCHEMES CLOAKED AS CHARITY

Sep 9, 2022

Researchers Say Brand Name Drug Companies’ So-Called Patient Assistance Read More

BIG PHARMA WATCH: DRUG COMPANIES ON PACE FOR RECORD 2022 LAUNCH PRICES

Aug 16, 2022

Analysis Finds Brand Name Manufacturers Bringing New Drugs to Market with Read More

BIG PHARMA WATCH: ABBVIE UTILIZED LOOPHOLES TO AVOID PAYING BILLIONS IN U.S. TAXES & FURTHER MAXIMIZE PROFITS WHILE HIKING PRICES

Jul 8, 2022

Committee Report Shows How Brand Name Drug Company Further Juiced Profits on Read More

BIG PHARMA WATCH: PHARMACEUTICAL COMPANIES HIKED LAUNCH PRICES BY 20 PERCENT EVERY YEAR FOR 14 YEARS

Jun 9, 2022

Nearly Half of All New Brand Name Drugs Cost More Than $150,000 Per Year In Read More

BIG PHARMA WATCH: REPORTS SHOW BIG PHARMA HAD ANOTHER BANNER YEAR IN 2021

Jun 3, 2022

Brand Name Drug Companies Posted Massive Profit Growth and Invested Heavily in Read More

BIG PHARMA WATCH: STUDY FINDS BIG PHARMA TARGETS MOST PROFITABLE DRUGS FOR NEW FORMULATIONS TO BLOCK COMPETITION

May 25, 2022

Brand Name Drug Companies Four Times as Likely to Reformulate Blockbuster Read More